Evidence map›Paper›PMID 32836361›Full record

ReviewIndian journal of orthopaedics2021

Adapting Management of Sarcomas in COVID-19: An Evidence-Based Review.

Ashish Gulia, Ramandeep Singh Arora, Pankaj Kumar Panda, Anand Raja, Akshay Tiwari, Sameer Bakhshi, Naveen Salins, Vineeta Goel, Amit Janu

Open access · bronzeAbstract readReview
In one paragraph

Review in Indian journal of orthopaedics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Assessment of patient satisfaction levels with teleconsultation services at a tertiary care cancer center in a developing country: a cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  3. Review
  4. Review
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Ashish GuliaBone and Soft Tissue Services, Department of Surgical Oncology, Tata Memorial Hospital, and Homi Bhabha National Institure (HBNI), Mumbai, India.ORCID 0000-0002-5133-7442
Ramandeep Singh AroraPaediatric Oncology, Max Super Speciality Hospital, New Delhi, India.
Pankaj Kumar PandaDepartment of Clinical Research, Apollo Proton Cancer Centre, Chennai, India.
Anand RajaDepartment of Surgical Oncology, Cancer Institute (WIA), Adyar, Chennai, India.
Akshay TiwariMusculoskeletal Oncology, Max Institute of Cancer Care, Saket, New Delhi, India.
Sameer BakhshiDepartment of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Naveen SalinsDepartment of Palliative Medicine and Supportive Care, Kasturba Medical College, MAHE, Manipal, India.
Vineeta GoelRadiation Oncology, Max Super Speciality Hospital, Shalimar Bagh, New Delhi, India.
Amit JanuDepartment of Radiology, Tata Memorial Hospital, and Homi Bhabha National Institure (HBNI), Mumbai, India.
Homi Bhabha National Institute · INMax Super Speciality Hospital · INAll India Institute of Medical Sciences Raipur · INApollo Proton Cancer Centre · INCancer Institute (WIA) · INKasturba Medical College, Manipal · INMax Healthcare · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the novel coronavirus disease (COVID-19) being declared a global pandemic by the World Health Organization, the Indian healthcare sector is at the forefront to deliver optimal care. Patients with cancer especially are at serious risk for increased chances of morbidity and mortality due to their immunocompromised state. Currently there is a paucity of definitive guidelines for the management of sarcomas during the pandemic in a resource-constrained and diverse population setting like India. Health care professionals from various specialties involved in the management of sarcomas have collaborated to discuss various aspects of evidence-based sarcoma management during the COVID-19 pandemic. This article provides structured recommendations for HCP to adapt to the situation, optimize treatment protocols with judicious use of all resources while providing evidence-based treatment for sarcoma patients.

Indexed as

COVID-19IndiaSarcomaTreatment guidelines

Identifiers

PMID32836361
PMCPMC7261215
OpenAlexW3028798538

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.